Neurotherapeutics and Case Studies
Neurotherapy teaches a person to produce better EEG patterns with positive strength. The customer is connected to EEG sensors that measure brain activity during a neurofeedback session. Connect the sensors to a computer, and the EEG signals control simple computer games. A type of alternative therapy, specifically one type of biofeedback that uses real-time electromephalography (EEG) displays to illustrate brain activity, is neurotherapy also known as neurofeedback (NFB), EEG biofeedback, or brainwave education.
Related Conference of Neurotherapeutics and Case Studies
September 15-16, 2025
29th International Conference on Neuropharmacology and Neurochemistry
Bangkok, Thailand
September 22-23, 2025
5th International Conference on Biomedicine & Pharmacotherapy
Amsterdam, Netherlands
Neurotherapeutics and Case Studies Conference Speakers
Recommended Sessions
- Brain Pathology and Oncology Research
- Brain Stimulation and Imaging
- Human Brain Mapping
- Neuropharmacology and genetic aspects of CNS function
- Neuropharmacology and Neurochemistry
- Neurotherapeutics and Case Studies
- Synaptic Function and Dysfunction in Brain Diseases
- Synaptic plasticity and memory
- Alzheimer’s and Parkinson’s Diseases
- Brain Injury and Behavioral Neuroscience
- Brain Structure and Function
- Clinical Neurophysiology and Stroke
- CNS and Brain Disorders
- Cognitive Neuroscience and Psychology
- Molecular and cellular neurochemistry
- Neurobiology and Behaviors
- Neurogenesis
- Neuroimmunology and Neurological Infections
- Neuroinformatics and Computational Neuroscience
- Neurological Disorders and Stroke
- Neurorehabilitation and Neural Repair
- Neuroscience and Artificial Intelligence
- Pre- and post-synaptic function
- Stem Cells Role in Neuro-Biological Treatment
- Synapse formation and neurotransmitter receptors
Related Journals
Are you interested in
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (Netherlands)
- Advances in Omics Technologies - BIOMEDICINE 2025 (Netherlands)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (Netherlands)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (Thailand)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (Netherlands)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (Thailand)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (Thailand)
- Brain Structure and Function - Neuropharmaceutics 2025 (Thailand)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (Thailand)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (Thailand)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (Thailand)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (Netherlands)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (Netherlands)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (Netherlands)
- Human Brain Mapping - Neuropharmaceutics 2025 (Thailand)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (Netherlands)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (Netherlands)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (Netherlands)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (Netherlands)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (Thailand)
- Neurogenesis - Neuropharmaceutics 2025 (Thailand)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (Thailand)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (Netherlands)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (Thailand)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (Thailand)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (Thailand)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (Netherlands)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (Netherlands)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (Thailand)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (Netherlands)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (Netherlands)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (Netherlands)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (Thailand)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (Thailand)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (Thailand)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (Thailand)